4th International Conference on Influenza and Zoonotic Diseases
4th International Conference on Influenza and Zoonotic diseases
July 02-03, 2018 Vienna, Austria
Influenza is a highly contagious disease affecting almost all mammals and birds. In contrast to the regular seasonal epidemics of influenza, Influenza pandemics occur irregularly, with the 1918 Spanish flu the most serious pandemic in recorded history. The report says higher rates of drug-resistant bacterial infections could result in 10 million deaths a year by 2050. Flu is the most familiar respiratory infection in the world. In the United States alone, approximately 25 to 50 million people contract influenza each year. The influenza market consists of products to prevent, treat, and diagnose influenza viruses during both seasonal and pandemic episodes. Also included in the market is the stockpiling efforts and spending on new vaccine/therapeutic contracts. This year, the global market for products used in the fight against influenza will be worth an estimated $5.5 billion, according to a new technical market research report, the Global Influenza Market, from BCC Research. Market revenue is forecast to increase at a five-year compound annual growth rate (CAGR) of 8% from 2013 to 2018, totaling nearly $6 billion in 2018.
Influenza-2018 highlights the theme “New approaches to outbreak surveillance of Influenza and Zoonotic diseases” Which focuses knowledge and research in the field of Influenza, Zoonotic diseases and also other infectious diseases which have become progressively important to Public Health.
This International Meeting provides two days discussions on methods and strategies related to Influenza and Zoonotic diseases as well as explore new ideas and concepts on a global scale. This two day event provides a perfect platform for leading scientists, researchers, scholars, practitioners, health care experts, treatment providers, public health professionals, community health educators, members of academia, and other allied health professionals. Nurse Practitioners, Pharmacists, Physicians, Physician Assistants, and Social Workers, academia, students, researchers, faculty, Influenza associations and societies.
Tracks and Sessions:
Track 1:Influenza Outbreaks
Track 2:Current and Novel Approach for Influenza vaccines
Track 3:Influenza Vaccines and Vaccination
Track 4: Pathogenesis of Influenza Virus
Track 5:Influenza Viruses -Advance in Detection & Differentiation
Track 6:Epidemic Influenza
Track 7: Zoonotic Diseases: Global Infectious Disease Burden
Track 8:Tracking and Preventing Zoonotic Infectious diseases
Track 9:Influenza and other Respiratory Tract Infection Therapy
Track 10:Epidemiology of Zoonotic Influenza
Track 11:Evolution and Epidemiological Aspects of Influenza and Zoonotic Diseases
Track 12:Antiviral treatment for flu and public health policy
Special Benefits of Influenza 2018:
§ Live Streaming of talk
§ Poster Presentation
§ YRF and Student fellowship
We are putting together an agenda that address the driving developing new vaccines and antiviral drugs factors, policies and issues that will steer the development of Influenza research globally including commercialization, policies, reimbursement, pricing and more. We look forward to having you as a part of the Influenza 2018 Family.
Scientific Relationship Manager
Office Ph.: (702) 508-5200 Ext: 8035
via eventbrite, vienna, 1070, austria